Personalized onco-genomics

Personalized Onco-Genomics (POG) is a clinical research initiative that is focused on the application of genomic sequencing to inform treatment decisions for patients with certain types of cancer. The goal of POG is to identify potential therapeutic targets that are unique to each patient's individual cancer.

Overview

POG is a program that uses whole genome sequencing and transcriptome sequencing to identify genetic changes in a patient's cancer. These changes can then be used to guide the selection of targeted therapies that are most likely to be effective for that individual patient. The program is based on the premise that each patient's cancer is unique and that understanding the genetic changes that drive a patient's cancer can lead to more effective treatment.

Process

The POG process begins with the collection of a sample of the patient's cancer tissue, as well as a sample of their normal tissue. These samples are then sequenced to identify the genetic changes that are present in the cancer but not in the normal tissue. The results of this sequencing are then analyzed to identify potential therapeutic targets.

Once potential targets have been identified, a multidisciplinary team of experts, including oncologists, pathologists, geneticists, and bioinformaticians, reviews the results. This team then makes recommendations for potential targeted therapies based on the identified genetic changes.

Limitations

While POG has the potential to improve cancer treatment, there are several limitations to this approach. First, not all genetic changes identified through sequencing are actionable, meaning that there may not be a targeted therapy available that can effectively target the identified change. Second, even when a potential target is identified, it may not be possible to access the recommended therapy due to issues such as cost or availability. Finally, the effectiveness of targeted therapies can vary, and in some cases, the cancer may become resistant to the therapy over time.

Future Directions

Despite these limitations, the field of personalized onco-genomics is rapidly evolving, and new technologies and therapies are continually being developed. As our understanding of cancer genetics continues to grow, it is hoped that POG will become an increasingly important tool in the fight against cancer.

This article is a medical stub. You can help WikiMD by expanding it!
Most recent articles Ongoing trials	Wikipedia